These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 15308510)
1. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism. Hachulla E; Coghlan JG Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510 [TBL] [Abstract][Full Text] [Related]
2. [PAH and many other indications. Old and new endothelin receptor antagonists.]. Schmitz J; Holzgrabe U Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930 [No Abstract] [Full Text] [Related]
3. Bosentan therapy for pulmonary arterial hypertension. Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289 [TBL] [Abstract][Full Text] [Related]
11. Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade. Sharma S; Kashour T; Philipp R Tex Heart Inst J; 2005; 32(3):405-10. PubMed ID: 16392231 [TBL] [Abstract][Full Text] [Related]
12. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan. McLaughlin VV Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005 [TBL] [Abstract][Full Text] [Related]
13. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Denton CP; Humbert M; Rubin L; Black CM Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845 [TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonists as disease modifiers in systemic sclerosis. Shetty N; Derk CT Inflamm Allergy Drug Targets; 2011 Feb; 10(1):19-26. PubMed ID: 21184655 [TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonists -- their role in pulmonary medicine. Boniface S; Reynaud-Gaubert M Rev Mal Respir; 2011 Oct; 28(8):e94-e107. PubMed ID: 22099418 [TBL] [Abstract][Full Text] [Related]
17. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Abman SH Annu Rev Med; 2009; 60():13-23. PubMed ID: 18764741 [TBL] [Abstract][Full Text] [Related]
18. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.]. Pabst S; Hammerstingl C; Nickenig G; Skowasch D Pharm Unserer Zeit; 2010 Nov; 39(6):448-52. PubMed ID: 20967933 [No Abstract] [Full Text] [Related]